These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 17121981)

  • 1. Preparation of monoclonal antibodies for detection and identification of Francisella tularensis.
    Hotta A; Uda A; Fujita O; Tanabayashi K; Yamada A
    Clin Vaccine Immunol; 2007 Jan; 14(1):81-4. PubMed ID: 17121981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production and partial characterization of hybridoma clones secreting monoclonal antibodies against Francisella tularensis.
    Bhatti AR; Wong JP; Woods DE
    Hybridoma; 1993 Apr; 12(2):197-202. PubMed ID: 7686137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation and characterization of hybridoma antibodies for immunotherapy of tularemia.
    Lu Z; Roche MI; Hui JH; Unal B; Felgner PL; Gulati S; Madico G; Sharon J
    Immunol Lett; 2007 Oct; 112(2):92-103. PubMed ID: 17764754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The preventive activity of monoclonal antibodies specific to the lipopolysaccharide of Francisella tularensis].
    Khlebnikov VS; Vetchinin SS; Grechko GK; Averina AA; Golovlev IR; Averin SF; Zhemchugov VE; Konovalov SI; Anisimov GA; Afanas'ev SS
    Zh Mikrobiol Epidemiol Immunobiol; 1992; (9-10):67-70. PubMed ID: 1481610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy of tularemia: characterization of a monoclonal antibody reactive with Francisella tularensis.
    Narayanan RB; Drabick JJ; Williams JC; Fortier AH; Meltzer MS; Sadoff JC; Bolt CR; Nacy CA
    J Leukoc Biol; 1993 Jan; 53(1):112-6. PubMed ID: 8426087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of Francisella tularensis-specific antibodies in patients with tularemia by a novel competitive enzyme-linked immunosorbent assay.
    Sharma N; Hotta A; Yamamoto Y; Fujita O; Uda A; Morikawa S; Yamada A; Tanabayashi K
    Clin Vaccine Immunol; 2013 Jan; 20(1):9-16. PubMed ID: 23114700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The determination of the antigenic determinant of protective monoclonal antibodies specific to the Francisella tularensis lipopolysaccharide].
    Khlebnikov VS; Golovlev IR; Tokhtamysheva NV; Averin SF; Kulevatskiĭ DP; Grechko GK; Averina AA; Vetchinin SS
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (1):83-8. PubMed ID: 7520655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoglobulin G subclass switching impacts sensitivity of an immunoassay targeting Francisella tularensis lipopolysaccharide.
    Nualnoi T; Kirosingh A; Basallo K; Hau D; Gates-Hollingsworth MA; Thorkildson P; Crump RB; Reed DE; Pandit S; AuCoin DP
    PLoS One; 2018; 13(4):e0195308. PubMed ID: 29630613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Francisella tularensis infection-derived monoclonal antibodies provide detection, protection, and therapy.
    Savitt AG; Mena-Taboada P; Monsalve G; Benach JL
    Clin Vaccine Immunol; 2009 Mar; 16(3):414-22. PubMed ID: 19176692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production and characterization of a monoclonal antibody to Francisella tularensis lipopolysaccharide.
    Gubbins MJ; Berry JD; Schmidt L; Cabral T; Kabani A; Tsang RS
    Hybridoma (Larchmt); 2007 Apr; 26(2):98-103. PubMed ID: 17451358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The characterization of Francisella tularensis mutants and subspecies by using monoclonal antibodies].
    Aleshkin GI; Efanova EA; Komissarova LV; Kozlovskiĭ VN; Rozhkov EV; Zakharenko VI
    Zh Mikrobiol Epidemiol Immunobiol; 1996; (4):18-22. PubMed ID: 9027167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of an immunoassay test system based on monoclonal antybodies and immunomagnetic particles for the detection of F. tularensis cells.
    Vetchinin SS; Shevyakov AG; Khomyakov AE; Mironova RI; Mokrievich AN; Biketov SF
    Klin Lab Diagn; 2021 Jun; 66(6):353-357. PubMed ID: 34105911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of antibodies to Francisella tularensis in cats.
    Magnarelli L; Levy S; Koski R
    Res Vet Sci; 2007 Feb; 82(1):22-6. PubMed ID: 16914176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The binding sites of monoclonal antibodies to the non-reducing end of Francisella tularensis O-antigen accommodate mainly the terminal saccharide.
    Lu Z; Rynkiewicz MJ; Yang CY; Madico G; Perkins HM; Wang Q; Costello CE; Zaia J; Seaton BA; Sharon J
    Immunology; 2013 Nov; 140(3):374-89. PubMed ID: 23844703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of murine monoclonal antibodies against Francisella tularensis antigens and characterization of antibody-reactive epitopes.
    Lilliehöök B; Sandström G
    Int Arch Allergy Appl Immunol; 1989; 90(1):71-7. PubMed ID: 2478486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical demonstration of Francisella tularensis in lesions of cats with tularemia.
    DeBey BM; Andrews GA; Chard-Bergstrom C; Cox L
    J Vet Diagn Invest; 2002 Mar; 14(2):162-4. PubMed ID: 11939340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibodies reacting specifically with Francisella sp.
    Greiser-Wilke I; Soiné C; Moennig V
    Zentralbl Veterinarmed B; 1989 Oct; 36(8):593-600. PubMed ID: 2596200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Development of a novel Francisella tularensis antigen stained with tetrazolium-blue for tularemia microagglutination test].
    Celebi B; Kılıç S
    Mikrobiyol Bul; 2013 Jul; 47(3):514-22. PubMed ID: 23971929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production and characterization of monoclonal antibodies directed against the lipopolysaccharide of Francisella tularensis.
    Fulop MJ; Webber T; Manchee RJ; Kelly DC
    J Clin Microbiol; 1991 Jul; 29(7):1407-12. PubMed ID: 1885735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple mechanisms mediate enhanced immunity generated by mAb-inactivated F. tularensis immunogen.
    Iglesias BV; Bitsaktsis C; Pham G; Drake JR; Hazlett KR; Porter K; Gosselin EJ
    Immunol Cell Biol; 2013 Feb; 91(2):139-48. PubMed ID: 23247654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.